Subscribe to read the full article
With an HSJ subscription you’ll get access to:
- Latest intelligence on NHS policy and agenda
- Which healthcare leadership teams are getting it right and why
- How innovation is driving quality and efficiency
For the best possible experience using our website we recommend you upgrade to a newer version or another browser.Close
Substituting expensive medicines for less costly alternatives might be a measure earmarked for cutting costs, but financial and legal issues surround this approach and need careful adherence, warns Peter Feldschreiber.
Alternatively register for guest access